WesBanco Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.91M | Buy |
162,515
+3,656
| +2% | +$95.6K | 0.1% | 162 |
|
|
2026
Q1 | $4.46M | Sell |
158,859
-19,046
| -11% | -$507K | 0.12% | 141 |
|
|
2025
Q4 | $4.43M | Sell |
177,905
-28,166
| -14% | -$710K | 0.12% | 142 |
|
|
2025
Q3 | $5.25M | Sell |
206,071
-8,167
| -4% | -$202K | 0.15% | 123 |
|
|
2025
Q2 | $5.19M | Buy |
214,238
+20,474
| +11% | +$477K | 0.15% | 120 |
|
|
2025
Q1 | $4.91M | Sell |
193,764
-5,898
| -3% | -$154K | 0.17% | 113 |
|
|
2024
Q4 | $5.3M | Sell |
199,662
-49,599
| -20% | -$1.35M | 0.18% | 109 |
|
|
2024
Q3 | $7.21M | Sell |
249,261
-2,684
| -1% | -$78.3K | 0.24% | 95 |
|
|
2024
Q2 | $7.05M | Buy |
251,945
+2,265
| +0.9% | +$62.4K | 0.26% | 89 |
|
|
2024
Q1 | $6.93M | Buy |
249,680
+53,190
| +27% | +$1.48M | 0.26% | 89 |
|
|
2023
Q4 | $5.66M | Sell |
196,490
-68,625
| -26% | -$2.07M | 0.32% | 84 |
|
|
2023
Q3 | $8.79M | Sell |
265,115
-10,686
| -4% | -$378K | 0.38% | 67 |
|
|
2023
Q2 | $10.1M | Buy |
275,801
+8,631
| +3% | +$336K | 0.43% | 63 |
|
|
2023
Q1 | $10.9M | Sell |
267,170
-821
| -0.3% | -$35.5K | 0.47% | 57 |
|
|
2022
Q4 | $13.7M | Buy |
267,991
+58,967
| +28% | +$2.83M | 0.61% | 44 |
|
|
2022
Q3 | $9.15M | Sell |
209,024
-86,287
| -29% | -$4.19M | 0.62% | 46 |
|
|
2022
Q2 | $15.5M | Sell |
295,311
-845
| -0.3% | -$43.1K | 0.68% | 32 |
|
|
2022
Q1 | $15.3M | Sell |
296,156
-2,462
| -0.8% | -$128K | 0.58% | 40 |
|
|
2021
Q4 | $17.6M | Sell |
298,618
-20,227
| -6% | -$1M | 0.64% | 37 |
|
|
2021
Q3 | $13.7M | Sell |
318,845
-2,873
| -0.9% | -$127K | 0.53% | 55 |
|
|
2021
Q2 | $12.6M | Sell |
321,718
-5,142
| -2% | -$200K | 0.47% | 60 |
|
|
2021
Q1 | $11.8M | Buy |
+326,860
| New | +$11.6M | 0.47% | 58 |
|
|
2020
Q3 | $12.2M | Buy |
351,069
+622
| +0.2% | +$21.8K | 0.57% | 51 |
|
|
2020
Q2 | $10.9M | Sell |
350,447
-7,632
| -2% | -$259K | 0.54% | 51 |
|
|
2020
Q1 | $11.1M | Sell |
358,079
-1,354
| -0.4% | -$46.1K | 0.64% | 45 |
|
|
2019
Q4 | $13.4M | Buy |
359,433
+475
| +0.1% | +$16.9K | 0.61% | 47 |
|
|
2019
Q3 | $12.2M | Sell |
358,958
-5,322
| -1% | -$194K | 0.61% | 48 |
|
|
2019
Q2 | $15M | Sell |
364,280
-2,221
| -0.6% | -$88.2K | 0.73% | 43 |
|
|
2019
Q1 | $14.8M | Buy |
366,501
+10,191
| +3% | +$408K | 0.74% | 40 |
|
|
2018
Q4 | $14.8M | Sell |
356,310
-1,046
| -0.3% | -$43.4K | 0.88% | 32 |
|
|
2018
Q3 | $14.9M | Sell |
357,356
-3,457
| -1% | -$133K | 0.74% | 36 |
|
|
2018
Q2 | $12.4M | Sell |
360,813
-18,678
| -5% | -$638K | 0.64% | 44 |
|
|
2018
Q1 | $12.8M | Buy |
379,491
+57,818
| +18% | +$1.99M | 0.65% | 44 |
|
|
2017
Q4 | $11.1M | Sell |
321,673
-65,625
| -17% | -$2.24M | 0.75% | 34 |
|
|
2017
Q3 | $13.1M | Sell |
387,298
-474
| -0.1% | -$15.2K | 0.68% | 43 |
|
|
2017
Q2 | $12.4M | Sell |
387,772
-2,000
| -0.5% | -$63.1K | 0.67% | 45 |
|
|
2017
Q1 | $12.7M | Sell |
389,772
-14,584
| -4% | -$460K | 0.7% | 39 |
|
|
2016
Q4 | $12.5M | Sell |
404,356
-75,013
| -16% | -$2.29M | 0.71% | 40 |
|
|
2016
Q3 | $15.4M | Buy |
479,369
+34,088
| +8% | +$1.14M | 0.91% | 28 |
|
|
2016
Q2 | $14.9M | Buy |
445,281
+55,243
| +14% | +$1.76M | 0.89% | 30 |
|
|
2016
Q1 | $11M | Buy |
390,038
+40,531
| +12% | +$1.16M | 0.65% | 47 |
|
|
2015
Q4 | $10.7M | Sell |
349,507
-1,238
| -0.4% | -$38.9K | 0.63% | 49 |
|
|
2015
Q3 | $10.5M | Buy |
350,745
+8,682
| +3% | +$278K | 0.63% | 46 |
|
|
2015
Q2 | $10.9M | Sell |
342,063
-13,647
| -4% | -$445K | 0.61% | 53 |
|
|
2015
Q1 | $11.7M | Buy |
355,710
+124
| +0% | +$3.94K | 0.65% | 47 |
|
|
2014
Q4 | $10.5M | Buy |
355,586
+20,785
| +6% | +$596K | 0.57% | 51 |
|
|
2014
Q3 | $9.39M | Sell |
334,801
-1,666
| -0.5% | -$46.8K | 0.53% | 57 |
|
|
2014
Q2 | $9.47M | Sell |
336,467
-6,759
| -2% | -$193K | 0.53% | 58 |
|
|
2014
Q1 | $10.5M | Sell |
343,226
-22,690
| -6% | -$677K | 0.6% | 51 |
|
|
2013
Q4 | $10.6M | Sell |
365,916
-9,450
| -3% | -$275K | 0.61% | 47 |
|
|
2013
Q3 | $10.2M | Sell |
375,366
-4,692
| -1% | -$128K | 0.63% | 42 |
|
|
2013
Q2 | $10.1M | Buy |
+380,058
| New | +$10.5M | 0.66% | 42 |
|
Other funds holding PFE
AIM
SLAM
CWP
WesBanco Bank's PFE Position: Q2 2026 in Review
WesBanco Bank increased its Pfizer (PFE) stake by 2.3% in Q2 2026, buying an estimated $95.6K and bringing the position to 162,515 shares worth $3.91M. The position accounts for 0.1% of the portfolio, ranked #162.
WesBanco Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.6M in Q4 2021. 1,328 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- WesBanco Bank held 162,515 shares of Pfizer worth $3.91M as of Q2 2026.
- WesBanco Bank bought 3,656 Pfizer shares in Q2 2026, an estimated $95.6K.
- Pfizer made up 0.1% of WesBanco Bank's portfolio in Q2 2026, its #162 holding.
- WesBanco Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- WesBanco Bank's Pfizer position peaked at $17.6M in Q4 2021.
- 1,328 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.